The Latest Breaking News from Pfizer

The Republic of Korea has donated over 500,000 doses of the bivalent Pfizer Covid-19 vaccine to Thailand to mark the 65th anniversary of diplomatic relations between the two countries.

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

The Public Health Ministry will begin the roll-out of Pfizer's BA.1 bivalent Covid-19 vaccine next month, according to Dr Thares Krasanairawiwong, chief of the Department of Disease Control (DDC).

Valneva stock plummeted Friday after Pfizer said it will drop roughly half of the participants enrolled in their Lyme disease vaccine study.

The protection against Covid-19 from being previously infected lasts at least as long as that offered by vaccination, one of the largest studies conducted on the subject said on Friday. Ten months after getting Covid, people still had an 88 percent lower risk of reinfection, hospitalization and death, according to…

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

Time is running out for free-to-consumer COVID-19 vaccines, at-home test kits and some treatments.

With Russia’s plans to cut crude oil production threatening to tip an interest-rate-paranoid market into a fresh bout of volatility and sell-off, shares of fundamentally strong and profitable businesses, such as Taiwan Semiconductor Manufacturing Company (TSM), Walmart (WMT), and Pfizer (PFE), seem to be good investments now. Continue reading….